Striatal Pre- and Postsynaptic Profile of Adenosine A2A Receptor Antagonists-Reference-Cited by-同舟云学术

Striatal Pre- and Postsynaptic Profile of Adenosine A2A Receptor Antagonists

Published:2011-01-11 Issue:1 Volume:6 Page:e16088
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Orru Marco,Bakešová Jana,Brugarolas Marc,Quiroz César,Beaumont Vahri,Goldberg Steven R.,Lluís Carme,Cortés Antoni,Franco Rafael,Casadó Vicent,Canela Enric I.,Ferré Sergi

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Basal Ganglia.;CR Gerfen,2004

2. The basal ganglia and disorders of movement: pathophysiological mechanisms.;JA Obeso;News Physiol Sci,2002

3. Circuits and circuit disorders of the basal ganglia.;MR DeLong;Arch Neurol,2007

4. An update on adenosine A2A-dopamine D2 receptor interactions: Implications for the function of G protein-coupled receptors.;S Ferre;Curr Pharm Des,2008

5. Key Modulatory Role of Presynaptic Adenosine A_2A Receptors in Cortical Neurotransmission to the Striatal Direct Pathway.;C Quiroz;TheScientificWorldJournal,2009

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adenosine A2A Receptor Blockade Provides More Effective Benefits at the Onset Rather than after Overt Neurodegeneration in a Rat Model of Parkinson’s Disease;International Journal of Molecular Sciences;2024-04-30

2. Targeting adenosine A2A receptors for early intervention of retinopathy of prematurity;Purinergic Signalling;2024-02-08

3. Enhancement of the Evoked Excitatory Transmission in the Nucleus Tractus Solitarius Neurons after Sustained Hypoxia in Mice Depends on A2A Receptors;Neuroscience;2024-01

4. Boolean analysis shows a high proportion of dopamine D2 receptors interacting with adenosine A2A receptors in striatal medium spiny neurons of mouse and non-human primate models of Parkinson's disease;Neurobiology of Disease;2023-11

5. Study of G protein-coupled receptors dimerization: From bivalent ligands to drug-like small molecules;Bioorganic Chemistry;2023-11